Showing results (261-270 of 781) with videos related to
Sort By:
Pageof 79
Hematology. American Society of Hematology. Education Program|February 20, 2015
Early or delayed transplantation for multiple myeloma in the era of novel therapy: does one size fit all?Paul G Richardson, Jacob P Laubach, Nikhil C Munshi, et al.Best Practice & Research. Clinical Haematology|December 12, 2007
The malignant clone and the bone-marrow environmentKlaus Podar, Paul G Richardson, Teru Hideshima, et al.Expert Review of Hematology|December 20, 2013
Future agents and treatment directions in multiple myelomaEnrique M Ocio, Constantine S Mitsiades, Robert Z Orlowski, et al.Expert Opinion on Drug Metabolism & Toxicology|April 20, 2012
Perifosine , an oral, anti-cancer agent and inhibitor of the Akt pathway: mechanistic actions, pharmacodynamics, pharmacokinetics, and clinical activityPaul G Richardson, Cathy Eng, Jill Kolesar, et al.Analytical Chemistry|March 12, 2014
A nano ultra-performance liquid chromatography-high resolution mass spectrometry approach for global metabolomic profiling and case study on drug-resistant multiple myelomaDrew R Jones, Zhiping Wu, Dharminder Chauhan, et al.Leukemia|March 16, 2019
Selective targeting of multiple myeloma by B cell maturation antigen (BCMA)-specific central memory CD8+ cytotoxic T lymphocytes: immunotherapeutic application in vaccination and adoptive immunotherapyJooeun Bae, Mehmet Samur, Paul Richardson, et al.Current Opinion in Hematology|September 28, 2007
Novel therapies in myelomaPatrick J Hayden, Constantine S Mitsiades, Kenneth C Anderson, et al.Blood|January 17, 2013
MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reactionLian Xu, Zachary R Hunter, Guang Yang, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 29, 2010
Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumorsMichel de Weers, Yu-Tzu Tai, Michael S van der Veer, et al.Lancet (London, England)|June 23, 2009
Multiple myelomaMarc S Raab, Klaus Podar, Iris Breitkreutz, et al.Pageof 79